FDA official questions need for advisory committees
FDA官员质疑是否有必要设立顾问委员会

A senior FDA official told reporters Thursday that the advisory committees the agency has used for years to gather outside perspective are “costly,” “slow” and use “pomp and flash instead of scientific truth.”
一位FDA高官周四对记者表示，该机构多年来用来征求外部意见的顾问委员会“成本高”、“进度慢”，而且“追求排场与噱头，而非科学真相”。